Natural History Evaluation of Charcot Marie Tooth Disease (CMT) Types CMT1B, CMT2A, CMT4A, CMT4C, and Others

Key facts

Sponsor

Michael Shy

Principal Investigator

Michael E Shy, MD

University of Iowa

Enrollment

5000 enrolled

Eligibility

All sexes

Timeline

2010 – 2026

Study locations (22)

• Cedars-Sinai Medical Center, Los Angeles, California, United States
• Stanford University, Palo Alto, California, United States
• University of Colorado Hospital, Aurora, Colorado, United States
• University of Connecticut/Connecticut Children's Medical Center, Hartford, Connecticut, United States
• Children's National Hospital, Washington D.C., District of Columbia, United States
• University of Miami, Miami, Florida, United States
• Nemours Children's Health, Orlando, Florida, United States
• Nemours Children's Hospital, Orlando, Florida, United States
• University of Iowa, Iowa City, Iowa, United States
• Johns Hopkins University, Baltimore, Maryland, United States
• Harvard/Massachusetts General Hospital, Boston, Massachusetts, United States
• University of Michigan, Ann Arbor, Michigan, United States
• University of Minnesota, Minneapolis, Minnesota, United States
• University of Rochester, Rochester, New York, United States
• Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
• +7 more locations on ClinicalTrials.gov

Collaborators

Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta · Johns Hopkins University · National Institute of Neurological Disorders and Stroke (NINDS) · King's College Hospital NHS Trust · Nemours Children's Hospital · Stanford University · University of Pennsylvania · University of Rochester · Children's Hospital of Philadelphia · Sydney Children's Hospitals Network · Rare Diseases Clinical Research Network · Muscular Dystrophy Association · National Institutes of Health (NIH) · Charcot-Marie-Tooth Association · Massachusetts General Hospital · Cedars-Sinai Medical Center · University of Miami · University of Minnesota · Connecticut Children's Medical Center · University of Colorado, Denver · The National Hospital for Neurology and Neurosurgery · Dubowitz Neuromuscular Centre

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Autosomal dominant Charcot-Marie-Tooth disease type 2

Additional recruiting or active studies for the same condition.

• RECRUITINGNCT01193088
  Genetics of Charcot Marie Tooth (CMT) - Modifiers of CMT1A, New Causes of CMT2
  University of Iowa

See all trials for Autosomal dominant Charcot-Marie-Tooth disease type 2 →